Site Listing

Please choose the site that is most convenient for you

Study Name: Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Wh
8 locations found